Therapy Areas: Inflammatory Diseases
17 January 2019 - Biotechnology company Therachon AG said on Wednesday that it has passed the US Food and Drug Administration's (FDA) orphan drug designation for apraglutide for the treatment of ...
17 January 2019 - Biotech company Bridge Biotherapeutics Inc revealed on Wednesday the receipt of the US Food and Drug Administration's (FDA) orphan drug designation (ODD) to promote the developm...
16 January 2019 - - US-based cancer immunotherapies developer CEL-SCI Corp. (NYSE American: CVM)  has received notification from the staff of the NYSE American, its current listing exchange,...
16 January 2019 - Botanical skin solutions company Kamedis revealed on Tuesday the receipt of US Patent and Trademark Office Notice of Allowance for the patent application for its Kamedis Calm Eczema ...
15 January 2019 - - US-based business intelligence and market research company Spherix Global Insights has published the third annual edition of RealWorld Dynamix: Biologic/JAK Switching in IBD, ...
15 January 2019 - iReceptor Plus stated on Tuesday that European Union (EU) and the Canadian government have awarded EUR8.4m under its international consortium project to promote human immunological d...
Related Headlines